1. HLA-G regulates the invasive properties of JEG-3 choriocarcinoma cells by controlling STAT3 activation.
   X Liu et al, 2013, Placenta CrossRef
2. Chondroitin sulfate proteoglycan protein is stimulated by interleukin 11 and promotes endometrial epithelial cancer cell proliferation and migration.
   Evdokia Dimitriadis, 0 CrossRef
3. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers
   Wei Kang, 2016, WJG CrossRef
4. Association of STAT3 with Cx26 and Cx43 in human uterine endometrioid adenocarcinoma
   URSZULA SULKOWSKA et al, 2016 CrossRef
5. Fibulin-5 localisation in human endometrial cancer shifts from epithelial to stromal with increasing tumour grade, and silencing promotes endometrial epithelial cancer cell proliferation.
   Evdokia Dimitriadis, 0 CrossRef
6. The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma
   Qianhui Li et al, 2018, Biomedicine & Pharmacotherapy CrossRef
7. Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy
   Jia Wei et al, 2019, J Exp Clin Cancer Res CrossRef
8. Characterization of the Transcriptional Complexity of the Receptive and Pre-receptive Endometria of Dairy Goats
   Lei Zhang et al, 2015, Sci Rep CrossRef
9. MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.
   Chi-Hau Chen et al, 2013, Gynecol Oncol CrossRef
10. Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells
    Barbara Onnis et al, 2013, J. Clin. Invest. CrossRef
11. YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11.
    Jing Wang et al, 2019, Mol Med CrossRef
12. IL-11/IL11RA receptor mediated signaling: a web accessible knowledgebase
    Lavanya Balakrishnan et al, 2013, Cell Communication & Adhesion CrossRef
13. Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
    Tracy L. Putoczki et al, 2013, Cancer Cell CrossRef
14. Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications
    Janani Kumar et al, 2014, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
15. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.
    Koji Taniguchi et al, 2014, Semin Immunol CrossRef
16. β1,6 GlcNAc Branches-Modified PTPRT Attenuates Its Activity and Promotes Cell Migration by STAT3 Pathway
    Jingjing Qi et al, 2014, PLoS ONE CrossRef
17. IL-6 Family and Cancer
    Arseniy E. Yuzhalin et al, 2015 CrossRef
18. Interleukin 11: similar or opposite roles in female reproduction and reproductive cancer?
    Amy Winship et al, 2016, Reprod. Fertil. Dev. CrossRef
19. Inhibition of the Interleukin-11-STAT3 Axis Attenuates Hypoxia-Induced Migration and Invasion in MDA-MB-231 Breast Cancer Cells
    Ji-Hong Lim, 2014, Korean J Physiol Pharmacol CrossRef
20. Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1
    Xuhui Zhang et al, 2015, J. Cell. Biochem. CrossRef
21. Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update.
    Annu Makker et al, 2016, Endocr Relat Cancer CrossRef
22. Interleukin-6 affects cancer cell biology
    Hiroshi Nishino, 2016, Journal of Japan Society of Immunology & Allergology in Otolaryngology CrossRef
23. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer
    Jingjing Wu et al, 2016, CARCIN CrossRef
24. A panoramic review and in silico analysis of IL-11 structure and function
    Manica Negahdaripour et al, 2016, Cytokine & Growth Factor Reviews CrossRef
25. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles
    Shehua Qian et al, 2019, EPMA Journal CrossRef
26. Zac1 regulates IL-11 expression in osteoarthritis
    Chun-Lin Kuo et al, 2018, Oncotarget CrossRef
27. Therapeutically blocking Interleukin-11 Receptor-α enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours.
    Evdokia Dimitriadis, 0 CrossRef
28. Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation
    Zhaoming Zhong et al, 2016, Oncotarget CrossRef
29. miR‑23b inhibits proliferation of SMMC‑7721 cells by directly targeting IL‑11
    Tianpeng Jiang et al, 2018, Mol Med Report CrossRef
30. Loss of NFKB1 Results in Expression of Tumor Necrosis Factor and Activation of Signal Transducer and Activator of Transcription 1 to Promote Gastric Tumorigenesis in Mice
    Jun T. Low et al, 2020, Gastroenterology CrossRef
31. miR-202-3p overexpression attenuates endometriosis-like lesions by modulating YAP-dependent transcription of S100A6 in murine models
    Jing Lan et al, 2020, Life Sciences CrossRef
32. Targeting Interleukin-11 Receptor-α Impairs Human Endometrial Cancer Cell Proliferation and Invasion In Vitro and Reduces Tumor Growth and Metastasis In Vivo
    Amy L. Winship et al, 2016, Mol Cancer Ther CrossRef
33. Molecular pathways: IL11 as a tumor-promoting cytokine-translational implications for cancers.
    Matthias Ernst et al, 2014, Clin Cancer Res CrossRef
34. hsa_circ_0001610 knockdown modulates miR‐646‐STAT3 axis to suppress endometrial carcinoma progression
    Bo Wang et al, 2021, J Gene Med CrossRef
35. A TrkB–STAT3–miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells
    Wei Bao et al, 2013, Mol Cancer CrossRef
36. Emerging roles for IL-11 in inflammatory diseases
    Ka Yee Fung et al, 2022, Cytokine CrossRef
37. DGUOK-AS1 acts as a tumorpromoter through regulatingmiR-204-5p/IL-11 axis in breast cancer
    Yiran Liang et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
38. In Silico Identification and Clinical Validation of a Novel Long Non-Coding RNA/mRNA/miRNA Molecular Network for Potential Biomarkers for Discriminating SARS CoV-2 Infection Severity
    Sara H. A. Agwa et al, 2021, Cells CrossRef
39. Adipocytokines and disease progression in endometrial cancer: a systematic review
    Irene Ray et al, 2021, Cancer Metastasis Rev CrossRef
40. The roles and therapeutic applications of cytokines in endometrial cancer
    Malihe Azadehrah et al, 2022, Journal of Reproductive Immunology CrossRef
41. Mutational Analysis of Interleukin-11 and its Consequences on Cancer and COVID-19 Related Cytokine Storm -An Extensive Molecular Dynamics Study
    Sujay Ray et al, 2022, PPL CrossRef
42. STAT3 inhibitor BBI608 reduces patient-specific primary cell viability of cervical and endometrial cancer at a clinical-relevant concentration.
    Jing Chen et al, 2023, Clin Transl Oncol CrossRef
43. The roles and clinical applications of interleukins in endometrial carcinoma
    Yuqin Zang et al, 2022, Front. Oncol. CrossRef
44. Changes in the Extracellular Matrix in Endometrial and Cervical Cancer: A Systematic Review
    Tjaša Padežnik et al, 2023, IJMS CrossRef
45. Features of the immunosuppressive tumor microenvironment in endometrial cancer based on molecular subtype
    Chong Zhang et al, 2023, Front. Oncol. CrossRef
46. Structures of the interleukin 11 signalling complex reveal gp130 dynamics and the inhibitory mechanism of a cytokine variant
    Riley D. Metcalfe et al, 2023, Nat Commun CrossRef
47. FKBP38 suppresses endometrial cancer cell proliferation and metastasis by inhibiting the mTOR pathway
    Yunjing Yan et al, 2024, Archives of Biochemistry and Biophysics CrossRef
48. Interleukin-11/IL-11 Receptor Promotes Glioblastoma Cell Proliferation, Epithelial–Mesenchymal Transition, and Invasion
    Sarah F. Stuart et al, 2024, Brain Sciences CrossRef
49. Cytokines: Role in Homeostasis and Disease States
    Anna Engstrom et al, 2024 CrossRef